Protein S deficiency

Haematologica

Volumn 93, Issue 4, 2008, Pages 498-501

  D'Angelo, Armando ^a   D'Angelo, Silvana Viganò ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN S;

DISEASE ASSOCIATION; EDITORIAL; HUMAN; MISSENSE MUTATION; NONHUMAN; PROTEIN BINDING; PROTEIN S DEFICIENCY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; ENZYME ACTIVATION; HUMANS; MUTATION; PROTEIN C; PROTEIN S; PROTEIN S DEFICIENCY; RECURRENCE; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 42149191952     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12691     Document Type: Editorial

References (35)

1. Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974;71:2730-3.
2. Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977;16:698-706.
3. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980;255:5521-4.
4. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994;269:18735-8.
5. Dahlbäck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981;78:2512-6.
6. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein J Biol Chem 1986;261:12022-7.
7. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984;74:2082-8.
8. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-8.
9. Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: The Molecular Basis of Blood Disease. 3rd ed. W.B. Saunders Company, Philadelphia, 2000: pp.614-656.
10. Drakenberg T, Ghasriani H, Thulin E, Thämlitz AM, Muranyi A, Annila A, Stenflo J. Solution structure of the Ca2+-binding EGF3-4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3. Biochemistry 2005;44:8782-9.
11. Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C: protein S modulates factor Xa protection. J Biol Chem 1988;263:14884-90.
12. Yegneswaran S, Wood GM, Esmon CT, Johnson A. Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography. J Biol Chem 1997;272:25013-21.
13. Heeb MJ, Koenen RR, Fernandez JA, Hackeng TM. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals. J Thromb Haemost 2004; 2: 1766-73.
14. van't Veer C, Hackeng TM, Biesbroeck D, Sixma JJ, Bouma BNl. Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma. Blood 1995;85:1815-21.
15. Hackeng T, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006;103:3106-11.
16. Esmon CT. The protein C pathway. Chest 2003;124:26S-32S.
17. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kB and mitogen-activated protein kinase pathways. J Exp Med 2002;196:565-77.
18. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003;4:87-91.
19. Kask L, Trouw LA, Dahlbäck B, Blom AM. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J Biol Chem 2004;279:23869-73.
20. Liu D, Guo H, Griffin JH, Fernandez JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation 2003;107:1791-6.
21. Viganò D'Angelo S, D'Angelo A, Kaufman CE Jr, Sholer C, Esmon CT, Comp PC. Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med 1987;107:42-7.
22. D'Angelo A, Viganò D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 1988;81:1445-54.
23. Viganò D'Angelo S, Gugliotta L, Mattioli Belmonte M, Cascione ML, Pattarini E, D'Angelo A. L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation. Thromb Res 1990;59:985-94.
24. D'Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi LM, Viganò D'Angelo S. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J med 1993;328:1753-7.
25. Bergamnn F, Hoyer PF, Viganò D'Angelo S, Mazzola G, Oestereich C, Barthels M, D'Angelo A. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol 1995;89:610-4.
26. Kasuno K, Tsuzuki D, Tanaka A, Ueda S, Sugawara A, Senzaki H, Kuwahara Tl. A 41-year old woman with protein S deficiency and diffuse proliferative lupus nephritis: is protein S deficiency associated with a hyperinflammatory response? Am J Kidney Dis 1997;29:931-5.
27. Safa O, Esmon CT, Esmon NL. Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-β2-glycoprotein I monoclonal antibodies. Blood 2005;106:1629-35.
28. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349-66.
29. Zöller B, Garcia de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood. 1995;85:3524-31.
30. Borgel D, Duchemin J, Alhenc-Gelas M, Matheron C, Aiach M, Gandrille S, and the French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. J Lab Clin Med 1996;128:218-27.
31. Viganò D'Angelo S, Mazzola G, Della Valle P, Testa S, Pattarini E, D'Angelo A. Variable interference of activated protein C resistance in the measurement of protein S activity by commercial assays. Thromb Res 1995; 77:375-8.
32. Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2007;98:543-56.
33. Baroni M, Mazzola G, Kaabache T, Borgel D, Gandrille S, Viganò D'Angelo S, et al. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function. J Thromb Haemost 2006;4:186-91.
34. Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, et al. Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Protein S deficiency: a data-base of mutations-summary of the first update. Thromb Haemost 2000;84:918.
35. Hurtado B, Muñoz X, Mulero MC, Navarro G, Domènech P, García de Frutos P, et al. Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency. Haematologica 2008; 93:574-80.